LONDON (Alliance News) - Sphere Medical Holding PLC said Tuesday it has seen a positive outcome for its post market clinical follow-up study of its monitoring system Proxima.
The study, conducted at the Queen Elizabeth Hospital in Birmingham, met its primary endpoint to show it gives the same clinical results as a bench top blood gas analyser. Results from the study are being prepared for submission to a clinical journal.
Proxima is a patient-attached arterial blood gas analyser.
"These positive study findings validate the Proxima technology within a clinical setting," said Chief Executive Wolfgang Rencken in a statement. "We believe that Proxima is well suited to enable nurses and clinicians to more closely manage their unstable and critically ill patients."
Shares in Sphere Medical are trading up 7.9% at 30.22 pence Tuesday morning.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.